Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 Network Model to Evaluate Vaccine Strategies towards Herd Immunity

Josephine N. A. Tetteh, Van Kinh Nguyen, Esteban A. Hernandez-Vargas
doi: https://doi.org/10.1101/2020.12.22.20248693
Josephine N. A. Tetteh
1Frankfurt Institute for Advanced Studies, Frankfurt am Main, Germany
4Institut für Mathematik, Goethe-Universität, Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Van Kinh Nguyen
2Imperial College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esteban A. Hernandez-Vargas
1Frankfurt Institute for Advanced Studies, Frankfurt am Main, Germany
3Instituto de Matemáticas, Universidad Nacional Autonoma de Mexico, Boulevard Juriquilla 3001, Santiago de Querétaro, Qro., 76230, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vargas@fias.uni-frankfurt.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

With more than 60 million confirmed cases and more than 1.5 million deaths, SARS-CoV-2 has paralyzed our societies, leading to self isolation and quarantine for several months. A COVID-19 vaccine remains a critical element in the eventual solution to this public health crisis. Two vaccines are ready to be mass produced and eventually supplied to the population. Here, we develop an epidemiological network model able to represent COVID-19 pandemic dynamics of different countries such as in Italy. Stochastic computational simulations identify the necessary number of vaccines and vaccine efficacy thresholds capable of preventing an epidemic whilst adhering to lockdown guidelines. Assuming a vaccine efficacy of 100% in a mass vaccination program, at least 60% of a given population should be vaccinated to obtain herd immunity. Otherwise, new waves of COVID-19 would be reported. However, reaching 60% of the population will be an unprecedented mass immunisation campaign that will take several months and millions of dollars. If the vaccine efficacy reports lower levels of efficacy in practice, then the coverage of vaccination would be needed to be even higher. Simulations suggest that the “Ring of Vaccination” strategy, vaccinating susceptible contact and contact of contacts, would be a more tractable vaccine strategy to prevent the new waves of COVID-19 meanwhile a high percent of the population is vaccinated.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work is supported by the Deutsche Forschungsgemeinschaft (HE7707/5-1), the Alfons und Gertrud Kassel-Stiftung and the Mexican National Science and Technology Council (CONACYT)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

-

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The code and the data-sets supporting this article have been uploaded as electronic supplementary material.

https://github.com/Josephine-Tetteh/COVID-19-Network-Model.git

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted December 22, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 Network Model to Evaluate Vaccine Strategies towards Herd Immunity
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 Network Model to Evaluate Vaccine Strategies towards Herd Immunity
Josephine N. A. Tetteh, Van Kinh Nguyen, Esteban A. Hernandez-Vargas
medRxiv 2020.12.22.20248693; doi: https://doi.org/10.1101/2020.12.22.20248693
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 Network Model to Evaluate Vaccine Strategies towards Herd Immunity
Josephine N. A. Tetteh, Van Kinh Nguyen, Esteban A. Hernandez-Vargas
medRxiv 2020.12.22.20248693; doi: https://doi.org/10.1101/2020.12.22.20248693

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1096)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9772)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2313)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1561)
  • Health Policy (736)
  • Health Systems and Quality Improvement (603)
  • Hematology (238)
  • HIV/AIDS (504)
  • Infectious Diseases (except HIV/AIDS) (11649)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (238)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2144)
  • Nursing (134)
  • Nutrition (337)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1180)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2182)
  • Public and Global Health (4661)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)